A Phase II Study of the Combination of High-dose Methotrexate and Intrathecal Liposomal Cytarabine in Patients With Leptomeningeal Metastases With or Without Parenchymal Brain Involvement.
Phase of Trial: Phase II
Latest Information Update: 10 Jul 2017
At a glance
- Drugs Cytarabine (Primary) ; Methotrexate (Primary)
- Indications Breast cancer; Cancer metastases
- Focus Adverse reactions; Therapeutic Use
- 05 Apr 2012 Additional trial centers identified as reported by ClinicalTrials.gov.
- 23 Mar 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 21 Oct 2011 Additional lead trial center (National Cancer Institute) identified as reported by ClinicalTrials.gov.